These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7887063)
21. p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma. Barnhill RL; Castresana JS; Rubio MP; Martin MT; Idoate M; Vazquez JJ; Thor AD Mod Pathol; 1994 Jun; 7(5):533-5. PubMed ID: 7937717 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression. Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469 [TBL] [Abstract][Full Text] [Related]
23. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080 [TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797 [TBL] [Abstract][Full Text] [Related]
25. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Kleer CG; Giordano TJ; Braun T; Oberman HA Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524 [TBL] [Abstract][Full Text] [Related]
26. Significance of p53 expression in immature teratomas. Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994 [TBL] [Abstract][Full Text] [Related]
27. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331 [TBL] [Abstract][Full Text] [Related]
28. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis. Cury PM; Butcher DN; Corrin B; Nicholson AG J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the effectiveness of malignancy detection in body fluid examination by the cytopathology and hematology laboratories. Kendall B; Dunn C; Solanki P Arch Pathol Lab Med; 1997 Sep; 121(9):976-9. PubMed ID: 9302931 [TBL] [Abstract][Full Text] [Related]
30. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348 [TBL] [Abstract][Full Text] [Related]
31. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Yang J; Schnadig V; Logrono R; Wasserman PG Cancer; 2007 Oct; 111(5):306-15. PubMed ID: 17680588 [TBL] [Abstract][Full Text] [Related]
32. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Moriya T; Sakamoto K; Sasano H; Kawanaka M; Sonoo H; Manabe T; Ito J Mod Pathol; 2000 Jan; 13(1):13-8. PubMed ID: 10658905 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation. Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of the immunocytochemical study of body fluids. Li CY; Ziesmer SC; Wong YC; Yam LT Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517 [TBL] [Abstract][Full Text] [Related]
36. p53 immunolocalization in cell block preparations of squamous lesions of the neck: an adjunct to fine-needle aspiration diagnosis of malignancy. Khurana KK; Ramzy I; Truong LD Arch Pathol Lab Med; 1999 May; 123(5):421-5. PubMed ID: 10235501 [TBL] [Abstract][Full Text] [Related]
37. Detection of malignancy in body fluids: a comparison of the hematology and cytology laboratories. Jerz JL; Donohue RE; Mody RR; Schwartz MR; Mody DR; Zieske AW Arch Pathol Lab Med; 2014 May; 138(5):651-7. PubMed ID: 24786122 [TBL] [Abstract][Full Text] [Related]
38. Sensitivity and specificity of cytodiagnosis of body fluids in a laboratory of urgencies. Rocher AE; Guerra F; Rofrano J; Angeleri A; Canessa OE; Mendeluk GR; Palaoro LA Biotech Histochem; 2011 Oct; 86(5):326-32. PubMed ID: 20961211 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids. Ben-Ezra J; Stastny JF; Harris AC; Bork L; Frable WJ Am J Clin Pathol; 1994 Oct; 102(4):439-42. PubMed ID: 7942600 [TBL] [Abstract][Full Text] [Related]
40. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Dei Tos AP; Doglioni C; Laurino L; Barbareschi M; Fletcher CD Histopathology; 1993 Jan; 22(1):45-50. PubMed ID: 8436341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]